Mondaq All Regions: Food, Drugs, Healthcare, Life Sciences
Schoenherr Attorneys at Law
On 15 December 2017, the European Commission adopted secondary legislation clarifying the requirements for EU-wide tracking and security systems for tobacco products, the implementation...
Minden Gross LLP
On November 21, 2017, the Canadian Government released a consultation paper that contains regulatory proposals for the implementation of legal recreational cannabis.
Howie, Sacks & Henry
Preventable medical errors kill about 30,000 Canadians every year. To put those eye-popping numbers into perspective, the former president and CEO of Toronto's University Health Network...
Miller Thomson LLP
The stated intention of this legislation is to strengthen transparency and increase patient trust in the health care system.
Arnold & Porter Kaye Scholer LLP
Following the implementation of the new EudraVigilance system, reported in our previous post, and in an attempt to streamline the monitoring of safety signals in EudraVigilance, the EMA has recently announced that ...
Mason Hayes & Curran
Three important regulatory developments occurred during 2017 which may be of significant benefit to patients, families, practitioners and indemnifiers alike.
Kramer Levin Naftalis & Frankel LLP
Liquid alternative mutual fund specialist Catalyst Funds and BNP Paribas partnered to form the BNP Paribas Catalyst Systematic Alpha Index, a risk premia strategy that allocates between seven strategies ...
Reed Smith
A number of recent Congressional hearings focused on the opioid crisis, including the following:
Day Pitney LLP
Beginning January 16, the amount of compensation that a New Jersey healthcare provider can accept from pharmaceutical manufacturers for "bona fide services," ...
Wilson Elser Moskowitz Edelman & Dicker LLP
Recent developments in three New England states indicate that popular support for legalized marijuana is growing, even as the federal government reverses the hands-off policy of the previous administration.
Holland & Knight
On Jan. 4, 2018, the HHS Office of Inspector General (OIG) issued an open letter containing guidance regarding the provision of certain free drugs to federal healthcare program beneficiaries.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
I previously said that the year 2014 may be a game-changer for the 340B Drug Discount Program. Increasing HRSA audits, a lawsuit over the 340B Orphan Drug Rule, and HRSA's promise to issue...
Seyfarth Shaw LLP
In a recent article, senior officials with the Department of Justice's Office of the United States Trustee (the "UST"), the federal government's watchdog of the bankruptcy system ...
Troutman Sanders LLP
A case currently pending before the U.S. Court of Appeals for the D.C. Circuit challenges the applicability of the federal Contraband Cigarette Trafficking Act ("CCTA") to tribal entities.
Troutman Sanders LLP
Pending before the Mississippi Legislature is House Bill 906, which, if enacted, would increase the "tobacco equity tax" applicable to cigarettes manufactured by non-signatories ...
Reed Smith
As previously reported, the 21st Century Cures Act prohibits FFP payments to the states for certain Medicaid DME expenditures that exceed what Medicare would have paid for such items...
BakerHostetler
House Republicans will gather tonight for a GOP-only meeting to plot strategy on passing a stopgap budget bill, but a breakdown among key senators on separate immigration legislation ...
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Congress has four days to fund the government. The emerging spending deal could include any number of legislative priorities.
Archer & Greiner P.C.
The U.S. Department of Justice decision to rescind Obama-era guidance on marijuana enforcement elicited furious statements from lawmakers on both sides of the aisle.
Morrison & Foerster LLP
In December, the U.S. Food and Drug Administration (FDA) issued guidance on Technical Considerations for Additive Manufactured Medical Devices.
Latest Video
Most Popular Recent Articles
Norton Rose Fulbright Australia
Businesses in food and agriculture industries should be particularly alive to the risk of slavery in their supply chains.
Norton Rose Fulbright Australia
The article considers the responses to some of the key recommendations and potential implications of these responses.
Carroll & O'Dea
The appeal addressed how the trial judge could properly choose between competing expert opinions on mental harm.
Holman Webb
A genomic profile may help a doctor make personalised health decisions, but also raises a number of ethical challenges.
Holman Webb
Future action for non-compliance with the ACL in the marketing of therapeutic goods may result in much higher penalties.
Carroll & O'Dea
This article focuses on some information provision issues addressed in the new ethical guidelines on the use of ART.
Holman Webb
The Appeal decision confirms the need to understand medical malpractice and civil liability policy terms and conditions.
Carroll & O'Dea
The balancing exercise between confidentiality and the patient's potential risk to the community has become no easier.
Holman Webb
There are significant legal issues to consider for marketers of therapeutic goods.
Sparke Helmore Lawyers
A string of successful prosecutions by the Food Authority should alert businesses to comply with food safety obligations.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter